引用次数
引用: 13,361
H-指数: 63
I10-指数 : 165
出版物: 321
Ffects Of Strain-Induced Anisotropy In Permeability On The Deformation-Flow-Heat Transfer In Porous Media
Ron C.K. Wong , Edwin Choy , Jiancheng Du
Gulf Rocks 2004, the 6th North America Rock Mechanics Symposium (NARMS)
2004
Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma.
Henry Mankin , Kevin Raskin , Patrick Boland , John Iafrate
Anticancer Research 29 ( 6) 1867 -1871
46
2009
Histone Deacetylase Inhibitor PCI-24781 Enhances Chemotherapy-induced Apoptosis in Multidrug-resistant Sarcoma Cell Lines
Henry Mankin , Zhenfeng Duan , Kirkham B Wood , Edwin Choy
Anticancer Research 31 ( 4) 1115 -1123
21
2011
The emerging roles and therapeutic potential of microRNAs (miRs) in liposarcoma.
Zhenfeng Duan , Edwin Choy , Jacson K Shen , Francis J Hornicek
Discovery Medicine 20 ( 111) 311 -324
7
2015
Abstract #905: The small molecule Tetradrine (NSC77037), identified in a high-throughput cell-based screen, reverses multidrug resistance in cancer cells
Henry Mankin , Zhenfeng Duan , Edwin Choy , Francis Hornicek
Cancer Research 69 905 -905
2009
Lentiviral shRNA screen of multidrug resistant associated genes identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer
Henry Mankin , Zhenfeng Duan , Edwin Choy , Edward Weinstein
Cancer Research 68 720 -720
2008
Diverse cross-resistance phenotype to Yondelis (Trabectedin; ET-743) and Zalypsis (PM00104) in paclitaxel, doxorubicin and cisplatin selected multidrug resistant cell lines
Henry Mankin , Zhenfeng Duan , Edwin Choy , Francis Hornicek
Cancer Research 68 3219 -3219
1
2008
Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma
Luisa Cironi , Joseph M. Beechem , Kai W. Wucherpfennig , Kai W. Wucherpfennig
Nature Medicine 27 ( 2) 289 -300
46
2021
Nodal involvement and survival in synovial, clear cell, angio, rhabdo, and epithelioid sarcoma.
Haotong Wang , Ruoyu Miao , Alex Jacobson , Graham Boyd
Journal of Clinical Oncology 36 11567 -11567
2
2018
Phase 2 results of selinexor in advanced de-differentiated (DDLS) liposarcoma (SEAL) study: A phase 2/3, randomized, double blind, placebo controlled cross-over study.
Mrinal M. Gounder , Neeta Somaiah , Steven Attia , Sant P. Chawla
Journal of Clinical Oncology 36 11512 -11512
12
2018
Phase 2 trial of the novel multi-receptor tyrosine kinase inhibitor sitravatinib in well-differentiated/dedifferentiated liposarcoma.
Matthew Ingham , Shing Mirn Lee , Parag Patwardhan , Edwin Choy
Journal of Clinical Oncology 35
2
2017
Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to Paclitaxel
Xianzhe Liu , Yan Gao , Jacson Shen , Wen Yang
Molecular Cancer Therapeutics 15 ( 7) 1691 -1701
18
2016
Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosiss
Yan Gao , Jacson Shen , Edwin Choy , Henry Mankin
Cellular Oncology 40 ( 3) 209 -218
19
2017
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
Scott M. Schuetze , Vanessa Bolejack , Edwin Choy , Kristen N. Ganjoo
Cancer 123 ( 1) 90 -97
53
2017
SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma
Scott M. Schuetze , J. Kyle Wathen , David R. Lucas , Edwin Choy
Cancer 122 ( 6) 868 -874
52
2016
Sarcoma after 5 years of progression-free survival: lessons from the French sarcoma group.
Edwin Choy
Cancer 120 ( 19) 2942 -2943
2
2014
Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy.
John T. Mullen , Francis J. Hornicek , David C. Harmon , Kevin A. Raskin
Cancer 120 ( 23) 3676 -3682
43
2014
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma.
Edwin Choy , Yael Flamand , Sriram Balasubramanian , James E. Butrynski
Cancer 121 ( 8) 1223 -1230
35
2015
A Genome-wide Screen for Genetic Variants Affecting the Expression of Immunologically Relevant Cell Surface Markers
Philip De Jager , Roman Yelensky , Elizabeth Rossin , Sasha Bonadkar
Clinical Immunology 123
2007
Programmed cell death ligand 1 expression in osteosarcoma.
Jacson K. Shen , Gregory M. Cote , Edwin Choy , Pei Yang
Cancer immunology research 2 ( 7) 690 -698
114
2014